APA (7th ed.) Citation

DR, M., Q, L., V, P., KW, M., D, d. Z., G, F., . . . B, N. (2019). Effects of canagliflozin on amputation risk in type 2 diabetes: The CANVAS Program. Diabetologia, 62(6), 926. https://doi.org/10.1007/s00125-019-4839-8

Chicago Style (17th ed.) Citation

DR, Matthews, et al. "Effects of Canagliflozin on Amputation Risk in Type 2 Diabetes: The CANVAS Program." Diabetologia 62, no. 6 (2019): 926. https://doi.org/10.1007/s00125-019-4839-8.

MLA (9th ed.) Citation

DR, Matthews, et al. "Effects of Canagliflozin on Amputation Risk in Type 2 Diabetes: The CANVAS Program." Diabetologia, vol. 62, no. 6, 2019, p. 926, https://doi.org/10.1007/s00125-019-4839-8.